HomeBiotechnology

Biotechnology

Spark Therapeutics Prices Genetic Treatment at $850,000 and Stock Still Managed to Climb

Spark Therapeutics Prices Genetic Treatment at $850,000 and Stock Still Managed to Climb

January 3, 2018

Biotechnology the Market to Watch: The Top Two Percent Gainers on Nasdaq Today

Biotechnology the Market to Watch: The Top Two Percent Gainers on Nasdaq Today

January 2, 2018

Midatech Pharma Closes At 75% Over Previous Close – Will the Stock Continue to Rise?

Midatech Pharma Closes At 75% Over Previous Close – Will the Stock Continue to Rise?

January 2, 2018

Ignyta Inc. Investigation Continues

Ignyta Inc. Investigation Continues

December 29, 2017

BrainStorm Cell Therapeutics Stock Up Almost 30% After Company Sends Out Positive Letter to Shareholders

BrainStorm Cell Therapeutics Stock Up Almost 30% After Company Sends Out Positive Letter to Shareholders

December 29, 2017

Atara Biotherapeutics Gets FDA Approval and Stock Climbs Over 20%

Atara Biotherapeutics Gets FDA Approval and Stock Climbs Over 20%

December 29, 2017

Is vTv Therapeutics Making a Comeback? Stock up Almost 40% Despite Plunging on Dec. 25

Is vTv Therapeutics Making a Comeback? Stock up Almost 40% Despite Plunging on Dec. 25

December 28, 2017

Auris Medical Holding to Provide Update on Development Program with AM-111, Stock Jumps Almost 30%

Auris Medical Holding to Provide Update on Development Program with AM-111, Stock Jumps Almost 30%

December 28, 2017

Why is Ignyta, Inc. Under Investigation After Signing Deal with Roche Holding?

Why is Ignyta, Inc. Under Investigation After Signing Deal with Roche Holding?

December 22, 2017

Q BioMed Inc. Shares Up 10%, As Company Announces Big Movements In 2018 With Cancer Aid Drug

Q BioMed Inc. Shares Up 10%, As Company Announces Big Movements In 2018 With Cancer Aid Drug

December 22, 2017

« 1 … 6 7 8 9 10 … 14 »